Advanced Prognostic Predictive Modelling in Healthcare Data Analytics, Roy Sudipta, Goyal Lalit Mohan, Mittal Mamta
Автор: Rath Pragyan, Shalini Kumari Название: New Insights into Prognostic Data Analytics in Corporate Communication ISBN: 1947441108 ISBN-13(EAN): 9781947441101 Издательство: Mare Nostrum (Eurospan) Рейтинг: Цена: 3385.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This book advances diagnosis-prognosis models that mark antecedent frames in various commercial forms of communication-annual reports, investigative fiction-Poirot series, Sci-Fi, and advertisements.
The authors thereby develop a study of narrative markets by proposing the narrative of things as the next innovative mega trend in business analytics. A unique feature of the book is the special section dedicated to industry-academic practitioners, who have offered a bird's-eye view in the Review Speak section of every chapter of this book.
Описание: Discussing the methodologies involved in measuring and reporting, this book reviews the latest research from international regarding the identification of markers typing breast cancer behavior. It also examines the roles of major predictive markers such as the steroid receptors, p53, and HER-2. The book provides an overview of the prognostic and predictive factors, the role of the pathologist in prognostic factors, determination of occult auxiliary lymph node metastases, and risk factors for recurrence. That focus makes this text extremely useful for oncologists and researchers who want to learn more about best practices in prognoses.
Biomarkers are of critical medical importance for oncologists, allowing them to predict and detect disease and to determine the best course of action for cancer patient care. Prognostic markers are used to evaluate a patient's outcome and cancer recurrence probability after initial interventions such as surgery or drug treatments and, hence, to select follow-up and further treatment strategies. On the other hand, predictive markers are increasingly being used to evaluate the probability of benefit from clinical intervention(s), driving personalized medicine. Evolving technologies and the increasing availability of "multiomics" data are leading to the selection of numerous potential biomarkers, based on DNA, RNA, miRNA, protein, and metabolic alterations within cancer cells or tumor microenvironment, that may be combined with clinical and pathological data to greatly improve the prediction of both cancer progression and therapeutic treatment responses. However, in recent years, few biomarkers have progressed from discovery to become validated tools to be used in clinical practice. This Special Issue comprises eight review articles and five original studies on novel potential prognostic and predictive markers for different cancer types.
Автор: Walker Название: Prognostic and Predictive Factors in Breast Cancer 2E ISBN: 0415422256 ISBN-13(EAN): 9780415422253 Издательство: Taylor&Francis Рейтинг: Цена: 26796.00 р. Наличие на складе: Поставка под заказ.
Описание: The first edition of this groundbreaking text established itself as the definitive reference on a topic of extreme interest and relevance to those involved in breast cancer management.This new Second Edition is filled with over 250 full-color images, illustrations, and photographs, and showcases cutting-edge translational research not included in the first edition. The broader scope of information in this text is essential reading for gynecologic surgeons, oncologists, pathologists, and molecular biologists.
Автор: Antonio Russo; Stefano Iacobelli; Juan Iovanna Название: Diagnostic, Prognostic and Therapeutic Value of Gene Signatures ISBN: 1493962590 ISBN-13(EAN): 9781493962594 Издательство: Springer Рейтинг: Цена: 23757.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Gene expression studies have revealed diagnostic profiles and upregulation of specific pathways in many solid tumors. The explosion of new information in gene expression profiling could potentially lead to the development of tailored treatments in many solid tumors. In addition many studies are ongoing to validate these signatures also in predicting response to hormonal, chemotherapeutic and targeted agents in breast cancer as well as in other tumors. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures provides readers a useful and comprehensive resource about the range of applications of microarray technology in oncological diseases. Topics covered include gene signatures and soft tissue sarcomas, prognostic relevance of breast cancer signatures, gene expression profiling of colorectal cancer and liver metastasis, gene signatures in GISTs, CNVs and gene expression profiles in pancreatic cancer, and gene signatures in head/neck, lung and gastric tumors. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures will be of great value to residents and fellows, physicians, pathologists and medical oncologists.
Описание: This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.
Prognostic and Therapeutic Applications of RKIP in Cancer provides updated reviews on the chemistry, signaling, pre-clinical and clinical activities, and role of RKIP expression levels for diagnostics, prognosis and potential interventions. The development of novel compounds and conjugates that selectively induce RKIP expression in cancer open a novel era of new therapeutics and their potential in the treatment of highly resistant cancers and metastases. Edited and written by internationally renowned experts in the field of novel therapeutics for cancer, this book is a valuable source for cancer researchers, medical scientists, clinicians, clinical pharmacologists, and graduate students.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
